Investigation Overview
After Quest Diagnostics agreed to pay $241 million to settle a lawsuit that alleged the Company overcharged California's Medicaid program an investigation on behalf of on behalf of investors in shares of Quest Diagnostics Incorporated (NYSE:DGX) over possible breaches of fiduciary duties by certain officers and directors at Quest Diagnostics Inc. was announced. The investigation by a...
You must register (for free) or login to view the entire investigation.